Karen Bernstein

Co-Founder at BioCentury Publications, Inc.

Karen Bernstein

Karen Bernstein

Co-Founder at BioCentury Publications, Inc.

Overview
Career Highlights

BioCentury Publications, Inc.

RelSci Relationships

521

Birthday

1953

Age

68

Number of Awards

1

Relationships
RelSci Relationships are individuals Karen Bernstein likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman of the Board of Directors & Chief Executive Officer at Ovid Therapeutics, Inc.

Relationship likelihood: Strong

Founding President & Chief Executive Officer at Codiak BioSciences, Inc.

Relationship likelihood: Strong

Founder at Ovid Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder & Chairman at Castlight Health, Inc.

Relationship likelihood: Strong

Fund Advisor at Longwood Fund Management LLC

Relationship likelihood: Strong

President & Professor at Keck Graduate Institute of Applied Life Sciences

Relationship likelihood: Strong

Associate Professor of Administrative Sciences & Certificate Coordinator for Healthcare Management at Keck Graduate Institute of Applied Life Sciences

Relationship likelihood: Strong

Vice Chair & Associate Professor of Clinical & Administrative Sciences & Certificate Coordinator for Medication Therapy Outcomes at Keck Graduate Institute - School of Pharmacy

Relationship likelihood: Strong

Program Director, Master of Science in Human Genetics & Genetic Counseling & Professor of Practice at Keck Graduate Institute of Applied Life Sciences

Relationship likelihood: Strong

Chief Operating Officer at The Scripps Research Institute - California

Relationship likelihood: Strong

Paths to Karen Bernstein
Potential Connections via
Relationship Science
You
Karen Bernstein
Co-Founder at BioCentury Publications, Inc.
Education
PhD in Political Science

Stanford University, officially Leland Stanford Junior University, is a private research university in Stanford, California. Stanford was founded in 1885 by Leland and Jane Stanford in memory of their only child, Leland Stanford Jr., who had died of typhoid fever at age 15 the previous year. Stanford is generally ranked among the best universities in the world by academic publications. It is also one of the top fundraising institutions in the country, becoming the first school to raise more than a billion dollars in a year.

BA in Politics & History

Brandeis University is an American private research university with a liberal arts focus. It is located in Waltham, Massachusetts, 9 miles (14 km) west of Boston. The university has an enrollment of approximately 3,600 undergraduate and 2,200 graduate students.[4] It was tied for 32nd among national universities in the United States in U.S. News & World Report 's 2014 rankings. Forbes listed Brandeis University as number 51 among all national universities and liberal arts colleges combined in 2013. Brandeis was founded in 1948 as a nonsectarian Jewish community-sponsored coeducational institution on the site of the former Middlesex University. The university is named for Louis Brandeis (1856–1941), the first Jewish Justice of the Supreme Court of the United States.

Career History
Co-Founder
1992 - Current

BioCentury Publications, Inc. publishes a bioindustry news. It provides information, analysis and data for biotechnology and pharmaceutical companies, investors, academia, and government on the strategic issues essential to the formation, development and sustainability of life science ventures worldwide. The company was founded by David Flores and Karen Bernstein in 1992 and is headquartered in Redwood City, CA.

Boards & Committees
Director
2019 - Current

Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA.

Member, Board of Directors
2015 - Current

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.

Independent Director
2017 - 2019

Achaogen, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections. It offers Plazomicin to treat bacterial illness, such as complicated urinary tract infection, blood stream infections, and other infections due to MDR Enterobacteriaceae. The company was founded by Nathaniel E. David in June 2002 and is headquartered in South San Francisco, CA.

Member-Overseers Board
Current

The Scripps Research Institute (TSRI), one of the world's largest, private, non-profit research organizations, stands at the forefront of basic biomedical science, a vital segment of medical research that seeks to comprehend the most fundamental processes of life. Over the last decades, the institute has established a lengthy track record of major contributions to the betterment of health and the human condition. The institute — which is located on campuses in La Jolla, California, and Jupiter, Florida — has become internationally recognized for its research into immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune diseases, cardiovascular diseases, virology, and synthetic vaccine development. Particularly significant is the institute's study of the basic structure and design of biological molecules; in this arena TSRI is among a handful of the world's leading centers. The institute’s educational programs are also top-rate. The Kellogg School of Science and Technology is currently ranked among the best in the nation in its fields of biology and chemistry. Rather than isolating faculty members, students, and laboratories into separate and distinct disciplines, as is generally prescribed in universities, a cooperative, collaborative spirit is encouraged and embraced. While the level of scientific investigation is intense, the atmosphere is collegial, relaxed, and informal. Technicians, postdoctoral fellows, graduate students, and administrative support staff all are considered part of the team and are given the latitude and responsibility to accomplish their tasks so as to serve the best interests of science. The pursuit of scientific excellence is paramount and all efforts are directed toward that end. The bulk of the institute's funding is derived from the National Institutes of Health and other federal agencies. In today's environment of increasing competition for shrinking federal dollars, however, collaborative industrial partnerships with leading pharmaceutical companies provide additional funding in several areas key to the organization's research objectives. The Scripps Research Institute's adherence to the highest scientific standards, emphasis on a multidisciplinary approach to problem solving, participation in the perpetuation of knowledge through education, and continual pursuit of research excellence provide an unparalleled scientific environment.

Member, Board of Trustees
Current
Member, Advisory Board
Current
Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
2013
Silicon Valley Business Journal - 100 Most Influential Women
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Karen Bernstein. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Karen Bernstein's profile does not indicate a business or promotional relationship of any kind between RelSci and Karen Bernstein.